NO306619B1 - Farmasöytisk preparat inneholdende en hemmer av testosteron 5<alfa>-reduktaseaktivitet samt anvendelse av slik hemmer for fremstilling av et legemiddel - Google Patents
Farmasöytisk preparat inneholdende en hemmer av testosteron 5<alfa>-reduktaseaktivitet samt anvendelse av slik hemmer for fremstilling av et legemiddelInfo
- Publication number
- NO306619B1 NO306619B1 NO944458A NO944458A NO306619B1 NO 306619 B1 NO306619 B1 NO 306619B1 NO 944458 A NO944458 A NO 944458A NO 944458 A NO944458 A NO 944458A NO 306619 B1 NO306619 B1 NO 306619B1
- Authority
- NO
- Norway
- Prior art keywords
- inhibitor
- testosterone
- alfa
- medicament
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88696192A | 1992-05-21 | 1992-05-21 | |
PCT/CA1993/000192 WO1993023053A1 (en) | 1992-05-21 | 1993-05-06 | INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY |
Publications (3)
Publication Number | Publication Date |
---|---|
NO944458D0 NO944458D0 (no) | 1994-11-21 |
NO944458L NO944458L (no) | 1995-01-09 |
NO306619B1 true NO306619B1 (no) | 1999-11-29 |
Family
ID=25390152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944458A NO306619B1 (no) | 1992-05-21 | 1994-11-21 | Farmasöytisk preparat inneholdende en hemmer av testosteron 5<alfa>-reduktaseaktivitet samt anvendelse av slik hemmer for fremstilling av et legemiddel |
Country Status (20)
Country | Link |
---|---|
US (1) | US5494914A (uk) |
EP (1) | EP0641211A1 (uk) |
JP (1) | JPH07506575A (uk) |
KR (1) | KR950701527A (uk) |
AU (1) | AU4258493A (uk) |
CA (1) | CA2136304A1 (uk) |
CZ (1) | CZ286894A3 (uk) |
FI (1) | FI945457A (uk) |
HU (1) | HUT71514A (uk) |
IL (1) | IL105721A0 (uk) |
NO (1) | NO306619B1 (uk) |
NZ (1) | NZ247598A (uk) |
PH (1) | PH30247A (uk) |
PL (1) | PL175591B1 (uk) |
RU (1) | RU2141967C1 (uk) |
SK (1) | SK140494A3 (uk) |
TW (1) | TW239145B (uk) |
UA (1) | UA35589C2 (uk) |
WO (1) | WO1993023053A1 (uk) |
ZA (2) | ZA933441B (uk) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2135057A1 (en) * | 1992-05-20 | 1993-11-25 | Bruce E. Witzel | 17-amino substituted 4-azasteroid 5a-reductase inhibitors |
WO1993023420A1 (en) * | 1992-05-20 | 1993-11-25 | Merck & Co., Inc. | NEW 7β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS |
WO1993023419A1 (en) * | 1992-05-20 | 1993-11-25 | Merck & Co., Inc. | NEW 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-ONES AS 5α-REDUCTASE INHIBITORS |
WO1993023039A1 (en) * | 1992-05-20 | 1993-11-25 | Merck & Co., Inc. | Substituted 4-aza-5a-androstan-ones as 5a-reductase inhibitors |
WO1993023048A1 (en) * | 1992-05-20 | 1993-11-25 | Merck & Co., Inc. | 4-azasteroid 5-alpha-reductase inhibitors |
TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
TW408127B (en) * | 1993-09-17 | 2000-10-11 | Glaxo Inc | Androstenones |
US5547957A (en) * | 1993-10-15 | 1996-08-20 | Merck & Co., Inc. | Method of treating androgenic alopecia with 5-α reductase inhibitors |
CN1058499C (zh) * | 1993-10-21 | 2000-11-15 | 麦克公司 | 16-取代-4-氮杂-雄甾烷-5α-还原酶同工酶1抑制剂 |
US5817818A (en) * | 1994-09-16 | 1998-10-06 | Glaxo Wellcome Inc. | Androstenones |
US5541322A (en) * | 1994-10-14 | 1996-07-30 | Glaxo Wellcome Inc. | Synthesis of 6-azaandrostenones |
GB9506678D0 (en) * | 1995-03-31 | 1995-05-24 | Glaxo Inc | Substituted 6-azacholesten-3-ones |
US5763361A (en) * | 1995-10-23 | 1998-06-09 | Merck & Co., Inc. | 17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors |
US6365597B1 (en) | 1996-02-14 | 2002-04-02 | Aventis Pharmaceuticals Inc. | 4-aza steroids |
KR19990082543A (ko) * | 1996-02-14 | 1999-11-25 | 게리 디. 스트리트, 스티븐 엘. 네스비트 | 테스토스테론 5-알파-리덕타제 및 c17-20 리아제의 활성억제제로서의 17-베타-시클로프로필(아미노/옥시) 4-아자스테로이드 |
US5879711A (en) * | 1997-11-07 | 1999-03-09 | Sequeira; Joel A. | Stable antiandrogenic gel composition |
US5998427A (en) * | 1998-05-14 | 1999-12-07 | Glaxo Wellcome Inc. | Androstenones |
ATE290862T1 (de) * | 1999-01-25 | 2005-04-15 | Smithkline Beecham Corp | Anti-androgene und verfahren zur behandlung von krankheiten |
WO2001023405A2 (en) | 1999-09-30 | 2001-04-05 | Hollis-Eden Pharmaceuticals, Inc. | Therapeutic treatment of androgen receptor driven conditions |
US20060148725A1 (en) * | 2001-12-21 | 2006-07-06 | The Miriam Hospital | Selective 11beta HSD inhibitors and methods of use thereof |
WO2003059267A2 (en) * | 2001-12-21 | 2003-07-24 | Rhode Island Hospital | SELECTIVE 11β-HSD INHIBITORS AND METHODS FOR USE THEREOF |
CA2472475C (en) * | 2002-01-15 | 2010-05-18 | Merck & Co., Inc. | 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
EP1624876A2 (en) * | 2003-04-29 | 2006-02-15 | The Miriam Hospital | Selective testicular 11beta-hsd inhibitors and methods of use thereof |
WO2004100874A2 (en) * | 2003-05-07 | 2004-11-25 | Merck & Co., Inc. | Androgen receptor modulators and methods of use thereof |
JP2007522087A (ja) * | 2003-06-30 | 2007-08-09 | メルク エンド カムパニー インコーポレーテッド | アンドロゲン受容体モジュレータとしての17−アセトアミド−4−アザステロイド誘導体 |
AU2004255749B2 (en) * | 2003-06-30 | 2008-12-18 | Merck Sharp & Dohme Corp. | 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
EP1641535A4 (en) * | 2003-06-30 | 2008-05-14 | Merck & Co Inc | 17-ACETAMIDO-4-AZASTEROID DERIVATIVES AS ANDROGEN RECEPTOR MODULATORS |
US8481530B2 (en) * | 2006-12-01 | 2013-07-09 | The Research Foundation Of State University Of New York | 3β-hydroxysteroid dehydrogenase inhibitors |
MX360186B (es) | 2012-12-20 | 2018-10-24 | Solural Pharma ApS | Forma de dosificacion oral solida de derivado de testosterona. |
PL3157508T3 (pl) | 2014-06-19 | 2021-05-17 | Solural Pharma ApS | Związki lipofilowe w postaci stałej dawkowane doustnie |
Family Cites Families (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR883091A (fr) * | 1941-06-26 | 1943-06-23 | Zellwolle Kunstseide Ring Gmbh | Procédé de préparation de sulfate de sodium à partir de bains de précipitation de viscose et d'autres solutions industrielles utilisables de sulfates alcalins |
US3001988A (en) * | 1960-07-19 | 1961-09-26 | Searle & Co | 3-oxygenated 17beta-aminoalkanamidoandrost-4/5-enes, 5alpha-androstanes corresponding, and intermediates thereto |
US3300523A (en) * | 1965-04-21 | 1967-01-24 | Searle & Co | 3-oxygenated 17beta-oxy-17alpha-pregnen-20-yn-21-yltri (alkyl/aryl) silanes and congeneric 3-desoxy-3, 5-dienes |
FR1465544A (fr) * | 1965-11-29 | 1967-01-13 | Roussel Uclaf | Dérivés stéroïdes aromatiques substitués par un atome d'azote endocyclique et procédé de préparation |
US4161540A (en) * | 1966-08-22 | 1979-07-17 | Schering Corporation | Antiandrogenic agents and methods for the treatment of androgen dependent disease states |
US3995060A (en) * | 1972-06-20 | 1976-11-30 | Schering Corporation | Antiandrogenic agents and method for the treatment of androgen dependent disease states |
FR2092780A2 (en) * | 1970-06-18 | 1972-01-28 | Roussel Uclaf | 2-oxa-3-oxo-17-beta undecanoyloxy estra-4,9,11-triene - - long acting anabolic agent |
CA970692A (en) * | 1971-11-08 | 1975-07-08 | Walter Voigt | METHODS OF INHIBITING THE ACTIVITY OF TESTOSTERONE 5.alpha.-REDUCTASE |
FR2277082A1 (fr) * | 1974-07-04 | 1976-01-30 | Roussel Uclaf | Nouveaux heptenes derives de la testosterone, leur procede de preparation et leur application a la fabrication d'antigenes |
DE2438350C3 (de) * | 1974-08-09 | 1979-06-13 | Hoechst Ag, 6000 Frankfurt | Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
US4329364A (en) * | 1974-09-11 | 1982-05-11 | Schering Corporation | Antiandrogenic agents and methods for the treatment of androgen dependent disease states |
GR60362B (en) * | 1975-06-25 | 1978-05-19 | Leo Pharm Prod Ltd | Preparation process of new 16-ethers of fusidic acid derivatives |
IE44263B1 (en) * | 1975-12-03 | 1981-09-23 | Leo Pharm Prod Ltd | New fusidic acid derivatives |
US4087461A (en) * | 1976-02-26 | 1978-05-02 | The Johns Hopkins University | Anti-androgenic steroids |
DE2617646C2 (de) * | 1976-04-22 | 1986-07-31 | Hoechst Ag, 6230 Frankfurt | Nonapeptid-amide und Decapeptid-amide mit Gonadoliberin-Wirkung, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
US4055641A (en) * | 1976-05-10 | 1977-10-25 | Richardson-Merrell Inc. | Method of treating benign prostatic hypertrophy |
GB1524747A (en) * | 1976-05-11 | 1978-09-13 | Ici Ltd | Polypeptide |
US4088760A (en) * | 1976-06-23 | 1978-05-09 | Richardson-Merrell Inc. | Testosterone 5α-reductase inhibitors |
US4139638A (en) * | 1976-09-23 | 1979-02-13 | Schering Corporation | Methods for the treatment of hirsutism |
US4377584A (en) * | 1978-04-13 | 1983-03-22 | Merck & Co., Inc. | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors |
US4191759A (en) * | 1978-04-13 | 1980-03-04 | Merck & Co., Inc. | N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors |
US4235893A (en) * | 1978-05-08 | 1980-11-25 | Brodie Angela M | Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis |
NZ207413A (en) * | 1979-03-05 | 1984-11-09 | Wisconsin Alumni Res Found | Steroid intermediates in the preparation of 24,24-difluoro-25-hydroxy-vitamin d3 |
US4220775A (en) * | 1979-03-15 | 1980-09-02 | Merck & Co., Inc. | Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors |
FR2465486A1 (fr) * | 1979-09-21 | 1981-03-27 | Roussel Uclaf | Nouvelle application utilisant la lh-rh ou des agonistes |
NZ197008A (en) * | 1980-05-22 | 1984-10-19 | Ici Ltd | Acylanilide derivatives and pharmaceutical compositions |
DK465481A (da) * | 1980-11-21 | 1982-05-22 | Hoffmann La Roche | Fremgangsmaade til fremstilling af d-homostemoider |
FR2528434B1 (fr) * | 1982-06-11 | 1985-07-19 | Roussel Uclaf | Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament |
IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
DE3121152A1 (de) * | 1981-05-22 | 1982-12-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie" |
US4347363A (en) * | 1981-09-17 | 1982-08-31 | Sterling Drug Inc. | Process for preparing 1,2-dihydro-6-methyl-2-oxo-5-(pyridinyl)nicotinonitriles |
US4481190A (en) * | 1982-12-21 | 1984-11-06 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
DE3339295A1 (de) * | 1982-11-15 | 1984-05-17 | Schering AG, 1000 Berlin und 4709 Bergkamen | 4-hydroxy- und 4-acyloxy-4-androsten-3,17-dione zur verwendung bei der prophylaxe und therapie der prostatahyperplasie und diese enthaltende mittel fuer derartige verwendung |
GR79447B (uk) * | 1982-12-31 | 1984-10-30 | Mortimer Christopher H Dr | |
GB8311678D0 (en) * | 1983-04-28 | 1983-06-02 | Ici Plc | Phenol derivatives |
ES8502612A1 (es) * | 1983-06-15 | 1985-02-01 | Schering Ag | Procedimiento para la preparacion de 13a-alquilgonanos |
GB8327256D0 (en) * | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
NZ211145A (en) * | 1984-02-27 | 1988-10-28 | Merck & Co Inc | 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions |
EP0314199B1 (en) * | 1984-02-27 | 1991-09-18 | Merck & Co. Inc. | 17 beta-substituted-4-aza-5 alpha-androstenones and their use as 5 alpha-reductase inhibitors |
US4859681A (en) * | 1984-02-27 | 1989-08-22 | Merck & Co., Inc. | 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors |
US5049562A (en) * | 1984-02-27 | 1991-09-17 | Merck & Co., Inc. | 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors |
IE58417B1 (en) * | 1984-04-27 | 1993-09-22 | Ici Plc | Chemical derivatives |
GB8410901D0 (en) * | 1984-04-27 | 1984-06-06 | Ici Plc | Phenol derivatives |
GB8410899D0 (en) * | 1984-04-27 | 1984-06-06 | Ici Plc | Phenol derivatives |
US5053403A (en) * | 1984-05-11 | 1991-10-01 | Norman Orentreich | Methods for treatment of male-pattern baldness |
US4760053A (en) * | 1984-08-02 | 1988-07-26 | Fernand Labrie | Combination therapy for selected sex steroid dependent cancers |
DE3586053D1 (de) * | 1984-08-02 | 1992-06-17 | Labrie | Pharmazeutische zusammensetzung fuer die kombinationstherapie von hormonabhaengigem krebs. |
US5064813A (en) * | 1984-08-02 | 1991-11-12 | Fernand Labrie | Combination therapy for selected sex steroid dependent cancers |
US4659695A (en) * | 1985-02-08 | 1987-04-21 | Fernand Labrie | Method of treatment of prostate cancer |
US5023234A (en) * | 1985-02-08 | 1991-06-11 | Fernand Labrie | Combination male breast cancer therapy |
EP0177654B1 (fr) * | 1984-10-10 | 1989-05-31 | Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France | Association synergique contraceptive |
EP0188010A1 (en) * | 1985-01-14 | 1986-07-23 | Gist-Brocades N.V. | New process for the preparation of certain steroids, especially intermediates for the preparation of proligestone and related compounds, and new intermediates formed in this process |
NZ214998A (en) * | 1985-02-07 | 1989-06-28 | Schering Ag | 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions |
GB8505862D0 (en) * | 1985-03-07 | 1985-04-11 | Erba Farmitalia | Steroidic 5alpha-reductase inhibitors |
DE3607651A1 (de) * | 1986-03-06 | 1987-09-10 | Schering Ag | Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer |
GB8622330D0 (en) * | 1986-09-17 | 1986-10-22 | Erba Farmitalia | 4-substituted 6-alkylidenandrostene-3,17-dione derivatives |
DE3783007T2 (de) * | 1986-10-10 | 1993-07-01 | Roussel Uclaf | 9-alpha-hydroxysteroide, verfahren zu ihrer herstellung und verfahren zur herstellung der entsprechenden 9(11)-dehydro-derivate. |
US4845104A (en) * | 1986-11-20 | 1989-07-04 | Merck & Co., Inc. | Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones |
DE3780778T2 (de) * | 1986-11-20 | 1993-01-14 | Merck & Co Inc | Topisches arzneimittel enthaltend 17-beta-methoxy-carbonyl-4-methyl-4-aza-5-alpha-androst-1-en-3-one. |
IE60964B1 (en) * | 1986-12-11 | 1994-09-07 | Roussel Uclaf | Zootechnical compositions containing a beta-adrenergic |
IE60780B1 (en) * | 1987-01-23 | 1994-08-10 | Akzo Nv | New 11-aryl steroid derivatives |
US4888336A (en) * | 1987-01-28 | 1989-12-19 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
EP0285383B1 (en) * | 1987-04-03 | 1994-03-16 | Merck & Co. Inc. | Treatment of prostatic carcinoma with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones |
US5041433A (en) * | 1987-04-29 | 1991-08-20 | Smithkline Beecham Corporation | 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase |
KR970006473B1 (ko) * | 1987-06-08 | 1997-04-28 | 오노 화아마슈티칼 캄파니 리미팃드 | 신나모일아미드 유도체, 그들의 제조방법, 그들을 함유하는 제약학적 조성물 및 그들의 사용 |
NZ225100A (en) * | 1987-06-29 | 1991-09-25 | Merck & Co Inc | Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates |
EP0334425A1 (en) * | 1988-03-24 | 1989-09-27 | Akzo N.V. | Novel delta4 - androstene derivatives |
US5204337A (en) * | 1988-10-31 | 1993-04-20 | Endorecherche Inc. | Estrogen nucleus derivatives for use in inhibition of sex steroid activity |
US4970205A (en) * | 1988-12-23 | 1990-11-13 | Smithkline Beecham Corporation | Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase |
US4946834A (en) * | 1988-12-23 | 1990-08-07 | Smithkline Beecham Corporation | Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors |
US5026882A (en) * | 1988-12-23 | 1991-06-25 | Smithkline Beecham Corporation | Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase |
US4937237A (en) * | 1988-12-23 | 1990-06-26 | Smithkline Beckman Corporation | Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase |
KR0181264B1 (ko) * | 1989-07-07 | 1999-03-20 | 라브리 페르낭 | 성스테로이드 활성 억제용 안드로겐 유도체 |
CA2023157A1 (en) * | 1989-08-21 | 1991-02-22 | Gary H. Rasmusson | 17 beta-acyl-4-aza-5 alpha-androst-1-ene-3-ones as 5 alpha-reductase inhibitors |
US5032586A (en) * | 1989-08-24 | 1991-07-16 | Smithkline Beecham Corporation | 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase |
US5100917A (en) * | 1989-12-29 | 1992-03-31 | Merrell Dow Pharmaceuticals Inc. | Novel a-nor-steroid-3-carboxylic acid derivatives |
GB9002922D0 (en) * | 1990-02-09 | 1990-04-04 | Erba Carlo Spa | 17 beta-substituted-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation |
GB9004301D0 (en) * | 1990-02-26 | 1990-04-18 | Fujisawa Pharmaceutical Co | Indolebutyric acid derivatives and process for preparation thereof |
GB9011335D0 (en) * | 1990-05-21 | 1990-07-11 | Fujisawa Pharmaceutical Co | Indolebutyric acid derivatives and process for preparation thereof |
US5061802A (en) * | 1990-06-20 | 1991-10-29 | Merck & Co. Inc. | 17β-aminobenzoyl-4-aza-5α-androst-1-en-3-ones as benign prostatic hypertrophy agents |
US5061801A (en) * | 1990-09-24 | 1991-10-29 | Merck & Co., Inc. | Intermediate for making 3-oxo-4-aza-androst-1-ene 17β-ketones |
US5061803A (en) * | 1990-09-24 | 1991-10-29 | Merck & Co., Inc. | Process for making 17-beta alkanoyl 3-oxo-4-aza-5-α-androst-1-enes |
US5237064A (en) * | 1992-05-20 | 1993-08-17 | Merck & Co., Inc. | Process for producing 7β-substituted-aza-5αandrostan-3-ones |
-
1993
- 1993-05-06 RU RU94046057A patent/RU2141967C1/ru active
- 1993-05-06 UA UA94119055A patent/UA35589C2/uk unknown
- 1993-05-06 JP JP5519725A patent/JPH07506575A/ja not_active Ceased
- 1993-05-06 CZ CZ942868A patent/CZ286894A3/cs unknown
- 1993-05-06 HU HU9403334A patent/HUT71514A/hu unknown
- 1993-05-06 AU AU42584/93A patent/AU4258493A/en not_active Abandoned
- 1993-05-06 TW TW082103543A patent/TW239145B/zh active
- 1993-05-06 EP EP93911711A patent/EP0641211A1/en not_active Withdrawn
- 1993-05-06 PL PL93306308A patent/PL175591B1/pl unknown
- 1993-05-06 SK SK1404-94A patent/SK140494A3/sk unknown
- 1993-05-06 CA CA002136304A patent/CA2136304A1/en not_active Abandoned
- 1993-05-06 KR KR1019940704183A patent/KR950701527A/ko active IP Right Grant
- 1993-05-06 WO PCT/CA1993/000192 patent/WO1993023053A1/en not_active Application Discontinuation
- 1993-05-10 PH PH46162A patent/PH30247A/en unknown
- 1993-05-11 NZ NZ247598A patent/NZ247598A/en unknown
- 1993-05-17 IL IL105721A patent/IL105721A0/xx unknown
- 1993-05-18 ZA ZA933441A patent/ZA933441B/xx unknown
- 1993-05-21 ZA ZA933545A patent/ZA933545B/xx unknown
-
1994
- 1994-02-14 US US08/196,332 patent/US5494914A/en not_active Expired - Fee Related
- 1994-11-21 NO NO944458A patent/NO306619B1/no not_active IP Right Cessation
- 1994-11-21 FI FI945457A patent/FI945457A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
EP0641211A1 (en) | 1995-03-08 |
US5494914A (en) | 1996-02-27 |
PH30247A (en) | 1997-02-05 |
RU2141967C1 (ru) | 1999-11-27 |
IL105721A0 (en) | 1993-09-22 |
NO944458D0 (no) | 1994-11-21 |
FI945457A (fi) | 1995-01-16 |
SK140494A3 (en) | 1995-07-11 |
NZ247598A (en) | 1995-12-21 |
CZ286894A3 (en) | 1995-09-13 |
CA2136304A1 (en) | 1993-11-25 |
KR950701527A (ko) | 1995-04-28 |
AU4258493A (en) | 1993-12-13 |
TW239145B (uk) | 1995-01-21 |
UA35589C2 (uk) | 2001-04-16 |
NO944458L (no) | 1995-01-09 |
JPH07506575A (ja) | 1995-07-20 |
HUT71514A (en) | 1995-12-28 |
RU94046057A (ru) | 1996-10-10 |
WO1993023053A1 (en) | 1993-11-25 |
FI945457A0 (fi) | 1994-11-21 |
ZA933545B (en) | 1994-11-21 |
PL175591B1 (pl) | 1999-01-29 |
ZA933441B (en) | 1994-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO306619B1 (no) | Farmasöytisk preparat inneholdende en hemmer av testosteron 5<alfa>-reduktaseaktivitet samt anvendelse av slik hemmer for fremstilling av et legemiddel | |
NO308107B1 (no) | Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel | |
HUT66273A (en) | Pharmaceutical composition for the treatment of prostatic hyperplasia containing a 5-alpha-reductase inhibitor and an antiandrogen | |
PH30794A (en) | Inhibition of phosphatidylinositol 3-kinase with worthmannin and analogs thereof. | |
NO981911D0 (no) | Anvendelse av rhodaninderivater for fremstilling av et medikament for behandling av Alzheimer's sykdom | |
HUP9802034A3 (en) | Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin and use of the compounds | |
NO306235B1 (no) | Anvendelse av et legemiddel for behandling av artritt | |
ATE468850T1 (de) | Tramadolhaltiges arzneimittel mit gesteuerter wirkstoffabgabe | |
HK1005425A1 (en) | Use of 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the manufacture of a medicament for the treatment of restenosis | |
NO914036D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater | |
ATE208618T1 (de) | Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung | |
AU1893492A (en) | Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor | |
NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
BR9610821A (pt) | Derivado de aminoácido uso de um composto e medicamento contendo o mesmo | |
NO171214C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater | |
AU6168190A (en) | Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient | |
NO951880D0 (no) | Anordning til innånding av pulver | |
GB9226832D0 (en) | Pharmaceutical preparations for the treatment of psoriasis | |
AU1680292A (en) | Pharmaceutical combination for the treatment of prostatic cancer containing a 5 alpha reductase inhibitor and an antiandrogen | |
NO934057D0 (no) | Fremgangsmaate for fremstilling av rent nikkelhydroksyd samt anvendelse av dette | |
NO993627D0 (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
AU5534794A (en) | Plaster with a supply of a medically active substance | |
NO931400D0 (no) | Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav | |
NO307704B1 (no) | 8-trifluormetylkinolinkarboksylsyre-derivat, medisinsk preparat inneholdende derivatet, samt anvendelse av et medisinsk preparat | |
ZA932303B (en) | Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2002 |